Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5Tongue Neoplasms 4Head and Neck Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Squamous Cell 1Mucositis 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Glioma 1Glioblastoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

angiotensin I (1-7) 3apraglutide 1Vaccinium myrtillus extract 1Radiotherapy, Intensity-Modulated 1Lansoprazole 1Fibroblast Growth Factor 7 1Dexlansoprazole 1Cisplatin 1CBLB502 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Mucositis × Radiotherapy, Intensity-Modulated × Clear all
NCT01728480 2013-12-11

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 1 Withdrawn
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡